The presence of cytokines in Langerhans' cell histiocytosis

Journal of Pathology

Volumn 180, Issue 4, 1996, Pages 400-406

  De Graaf, Jan H ^a   Tamminga, Rienk Y J ^b   Dam Meiring, Anke ^a   Kamps, Willem A ^b   Timens, Wim ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

CD1a; Cytokines; Double staining; Histiocytosis X; Immunohistochemistry; Inflammation; Langerhans' cell histiocytosis; Macrophages; Multinucleated giant cells; Osteolysis

Indexed keywords

CYTOKINE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DOWN REGULATION; EOSINOPHIL; FEMALE; FIBROSIS; GIANT CELL; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LANGERHANS CELL; LYMPHOCYTE; MACROPHAGE; MALE; OSTEOLYSIS; PRIORITY JOURNAL;

ADOLESCENT; BONE AND BONES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GIANT CELLS; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; LANGERHANS CELLS; LYMPH NODES; MALE; SKIN;

EID: 0030443474     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199612)180:4<400::AID-PATH701>3.0.CO;2-W     Document Type: Article

References (37)

1. Favara BE. Langerhans' cell histiocytosis pathobiology and pathogenesis. Semin Oncol 1991; 18: 3-7.
2. Komp DM. Langerhans cell histiocytosis. N Engl J Med 1987; 316: 747-748.
3. Favara BE, McCarthy RC, Mierau GW. Histiocytosis X. Hum Pathol 1983; 14: 663-676.
4. Grundy P, Ellis R. Histiocytosis X: a review of the etiology, pathology, staging, and therapy. Med Pediatr Oncol 1986; 14: 45-50.
5. Broadbent V, Egeler RM, Nesbit ME Jr. Langerhans cell histiocytosis - clinical and epidemiological aspects. Br J Cancer 1994; 70: S11-S16.
6. Arenzana-Seisdedos F, Barbey S, Virelizier JL, Kornprobst M, Nezelof C, Histiocytosis X. Purified (T6+) cells from bone granuloma produce interleukin 1 and prostaglandin E2 in culture. J Clin Invest 1986; 77: 326-329.
7. Emile JF, Peuchmauer M, Fraitag S, Bodemer C, Brousse N. Immunohistochemical detection of granulocyte/macrophage colony-stimulating factor in Langerhans' cell histiocytosis. Histopathology 1993; 23: 327-332.
8. Hashimoto K, Kagetsu N, Taniguchi Y, Weintraub R, Chapman-Winokur RL, Kasiborski A. Immunohistochemistry and electron microscopy in Langerhans cell histiocytosis confined to the skin. J Am Acad Dermatol 1991; 25: 1044-1053.
9. Kannourakis G, Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br J Cancer 1994; 70: S37-S40.
10. De Graaf JH, Tamminga RYJ, Kamps WA, Timens W. Expression of cellular adhesion molecules in Langerhans' cell histiocytosis and normal Langerhans' cells. Am J Palhol 1995; 147: 1161-1171.
11. De Graaf JH, Tamminga RYJ, Kamps WA, Timens W. Langerhans' cell histiocytosis: expression of leukocyte cellular adhesion molecules suggests abnormal homing and differentiation. Am J Pathol 1994; 144: 466-472.
12. Rosol TJ, Capen CC. Biology of disease. Mechanisms of cancer-induced hypercalcemia. Lab Invest 1992; 67: 680-702.
13. Neumann C, Schaumberg-Lever G, Döpfer R, Kolde G. Interferon gamma is a marker for histiocytosis X cells in the skin. J Invest Dermatol 1988; 91: 280-282.
14. Favara BE, Jaffe R. The histopathology of Langerhans cell histiocytosis. Br J Cancer 1994; 70: S17-S23.
15. Fukuda Y, Basset F, Soler P, Ferrans VJ, Masugi Y, Crysal RG. Intraluminal fibrosis and elastic fiber degradation lead to lung remodeling in pulmonary Langerhans cell granulomatosis (histiocytosis X). Am J Pathol 1990; 137: 415-424.
16. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
17. Gauldie J, Jordana M, Cox G. Cytokines and pulmonary fibrosis. Thorax 1993; 48: 931-935.
18. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. Curr Opin Cell Biol 1994; 8: 823-831.
19. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988; 167: 700-705.
20. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258-261.
21. Santiago-Schwartz F, Divaris N, Kay C, Carsons SE. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development. Blood 1993; 82: 3019-3028.
22. Tazi A, Bouchonnet F, Grandsaigne M, Boumsell L, Hance AJ, Soler P. Evidence that granulocyte macrophage-colony-stimulating factors regulate the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 1993; 91: 566-576.
23. Kaplan G, Walsh G, Guido LS, et al. Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 1992; 175: 1717-1728.
24. Colasante A, Castrilli G, Aiello FB, Brunetti M, Musiani P. Role of cytokines in distribution and differentiation of dendritic cell/Langerhans' cell lineage in human primary carcinomas of the lung. Hum Pathol 1995; 26: 866-872.
25. Cumberbatch M, Kimber I. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 1992; 75: 257-263.
26. Cumberbatch M, Fielding I, Kimber I. Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-α. Immunology 1994; 81: 395-401.
27. Chang CH, Furue M, Tamaki K. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur J Immunol 1994; 24: 2889-2895.
28. Groves RW, Ross E, Barker JNWN, Ross JS, Camp RDR, MacDonald DM. Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin. J Invest Dermatol 1992; 98: 384-387.
29. Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1β induced transendothelial migration. J Immunol 1992; 149: 4021-4028.
30. Iademarco MF, Barks JL, Dean DC. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-α in cultured endothelial cells. J Clin Invest 1995; 95: 264-271.
31. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994; 179: 1145-1154.
32. Luetteke NC, Lee DC. Transforming growth factor alpha: expression, regulation and biological actions of its integral membrane precursor. Semin Cancer Biol 1990; 1: 265-275.
33. Hage C, Willman CL, Favara BE, Isaacson PG. Langerhans' cell histiocytosis (histiocytosis X); immunophenotype and growth fraction. Hum Pathol 1993; 24: 840-845.
34. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X) - a clonal proliferate disease. N Engl J Med 1994; 331: 154-160.
35. Kripke ML, Munn CG, Jeevan A, Tang J, Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 1990; 145: 2833-2838.
36. Murphy GF, Fonferko E, Flotte T, Bhan AK. Association of basal-lamina defects with epidermal and dermal T6-positive cells: evidence of Langerhans cell migration. Arch Dermatol Res 1985; 278: 126-132.
37. Bos JD, Kapsenberg ML. The skin immune system: progress in cutaneous biology. Immunol Today 1993; 14: 75-78.